1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The NCI Community Oncology Research Program: The New Mexico NCORP is sponsored by National Cancer Institute (NCI). This program aims to improve the quality of cancer care throughout New Mexico and eliminate the burden of differential cancer health outcomes in diverse populations, including American Indian, Hispanic, Caucasian, and rural populations.
It achieves this by building innovative statewide outreach programs and fostering collaborations between community health systems and academic affiliates to increase awareness, access, and participation in NCI-sponsored cancer screening, control, prevention, therapeutic, and care delivery clinical trials.
Get alerted about grants like this
Save a search for “National Cancer Institute (NCI)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Academic institutions and their community partnerships; specifically, the University of New Mexico Comprehensive Cancer Center serves as the primary academic hub, partnering with New Mexico health systems and community cancer care sites. Confirm the full requirements in the official notice before applying.
Applications for The NCI Community Oncology Research Program: The New Mexico NCORP are due July 31, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
The NCI Community Oncology Research Program: The New Mexico NCORP is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New Mexico. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is a grant from the National Institutes of Health (NIH) / National Cancer Institute (NCI) that funds early-stage postdoctoral researchers in cancer-related fields to transition to independent research careers. The award provides a mentored phase (K99) followed by an independent phase (R00), supporting investigators who do not require an extended period of supervised training beyond their doctoral degrees. Eligible applicants must hold a research or clinical doctoral degree and be postdoctoral fellows who have not yet established independent research careers. The March 11, 2026 due date applies; award amounts vary by project.